High Sensitivity C-Reactive Protein
Related entities
Findings (27)
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD
None
nullA normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.
Effect: null; DLR >0.80 for both CHD and CVD